APO Research
Talk to an analyst

APO RESEARCH · REPORT

Formulation Development CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Formulation Development CDMO Industry Growth and Trends Forecast to 2032

5 June 2026121 pages

Choose your research edition.

Industry ResearchFormulation Development CDMO Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Formulation Development CDMO Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Formulation Development CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Formulation Development CDMO Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Formulation Development CDMO Market Analysis and Forecast 2026-2032242 pages · $4,950 USD

Market perspective

According to APO Research, the global Formulation Development CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Formulation Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Formulation Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Formulation Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Formulation Development CDMO market include Lonza, Ascendia Pharmaceutical Solutions, Catalent, Cambrex, Serán Bioscience, Singota Solutions, Adragos Pharma, Meribel Pharma and Eurofins CDMO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Formulation Development CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Formulation Development CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Formulation Development CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Formulation Development CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Formulation Development CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Formulation Development CDMO Market by Company

Lonza

Ascendia Pharmaceutical Solutions

Catalent

Cambrex

Serán Bioscience

Singota Solutions

Adragos Pharma

Meribel Pharma

Eurofins CDMO

Skyepharma

Siegfried Group

Recipharm

CordenPharma

Thermo Fisher Scientific

Samsung Biologics

AGC Biologics

WuXi AppTec

Pharmaron

Asymchem

Huahai Pharma

Nipro Pharma

CMIC Group

Hovione

Formulation Development CDMO Segment by Type

Oral Solid Dosage Forms

Injectable Dosage Forms

Transdermal Dosage Forms

Others

Formulation Development CDMO Segment by Application

Small molecule chemical drugs

Biologics

Cell and gene therapy products

Others

Formulation Development CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Formulation Development CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Formulation Development CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Formulation Development CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Formulation Development CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Formulation Development CDMO Market Share by Region (2021-2026) Table 4. Global Formulation Development CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Formulation Development CDMO Market Share by Region (2027-2032) Table 6. Global Formulation Development CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Formulation Development CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Formulation Development CDMO Market Size Share by Type (2021-2026) Table 9. Global Formulation Development CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Formulation Development CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Formulation Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Formulation Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Formulation Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Formulation Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Formulation Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Formulation Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Formulation Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Formulation Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Formulation Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Formulation Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Formulation Development CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Formulation Development CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Formulation Development CDMO Market Size Share by Application (2021-2026) Table 24. Global Formulation Development CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Formulation Development CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Formulation Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Formulation Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Formulation Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Formulation Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Formulation Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Formulation Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Formulation Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Formulation Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Formulation Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Formulation Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Formulation Development CDMO Industry Trends Table 37. Formulation Development CDMO Industry Drivers Table 38. Formulation Development CDMO Industry Opportunities and Challenges Table 39. Formulation Development CDMO Industry Restraints Table 40. Global Formulation Development CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Formulation Development CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Formulation Development CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Formulation Development CDMO Key Company Headquarters & Area Served Table 44. Global Formulation Development CDMO Company, Product Type & Application Table 45. Global Formulation Development CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Formulation Development CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Formulation Development CDMO Product Portfolio Table 52. Lonza Recent Development Table 53. Ascendia Pharmaceutical Solutions Company Information Table 54. Ascendia Pharmaceutical Solutions Business Overview Table 55. Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Portfolio Table 57. Ascendia Pharmaceutical Solutions Recent Development Table 58. Catalent Company Information Table 59. Catalent Business Overview Table 60. Catalent Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Catalent Formulation Development CDMO Product Portfolio Table 62. Catalent Recent Development Table 63. Cambrex Company Information Table 64. Cambrex Business Overview Table 65. Cambrex Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Cambrex Formulation Development CDMO Product Portfolio Table 67. Cambrex Recent Development Table 68. Serán Bioscience Company Information Table 69. Serán Bioscience Business Overview Table 70. Serán Bioscience Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Serán Bioscience Formulation Development CDMO Product Portfolio Table 72. Serán Bioscience Recent Development Table 73. Singota Solutions Company Information Table 74. Singota Solutions Business Overview Table 75. Singota Solutions Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Singota Solutions Formulation Development CDMO Product Portfolio Table 77. Singota Solutions Recent Development Table 78. Adragos Pharma Company Information Table 79. Adragos Pharma Business Overview Table 80. Adragos Pharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Adragos Pharma Formulation Development CDMO Product Portfolio Table 82. Adragos Pharma Recent Development Table 83. Meribel Pharma Company Information Table 84. Meribel Pharma Business Overview Table 85. Meribel Pharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Meribel Pharma Formulation Development CDMO Product Portfolio Table 87. Meribel Pharma Recent Development Table 88. Eurofins CDMO Company Information Table 89. Eurofins CDMO Business Overview Table 90. Eurofins CDMO Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eurofins CDMO Formulation Development CDMO Product Portfolio Table 92. Eurofins CDMO Recent Development Table 93. Skyepharma Company Information Table 94. Skyepharma Business Overview Table 95. Skyepharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Skyepharma Formulation Development CDMO Product Portfolio Table 97. Skyepharma Recent Development Table 98. Siegfried Group Company Information Table 99. Siegfried Group Business Overview Table 100. Siegfried Group Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Siegfried Group Formulation Development CDMO Product Portfolio Table 102. Siegfried Group Recent Development Table 103. Recipharm Company Information Table 104. Recipharm Business Overview Table 105. Recipharm Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Recipharm Formulation Development CDMO Product Portfolio Table 107. Recipharm Recent Development Table 108. CordenPharma Company Information Table 109. CordenPharma Business Overview Table 110. CordenPharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. CordenPharma Formulation Development CDMO Product Portfolio Table 112. CordenPharma Recent Development Table 113. Thermo Fisher Scientific Company Information Table 114. Thermo Fisher Scientific Business Overview Table 115. Thermo Fisher Scientific Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Thermo Fisher Scientific Formulation Development CDMO Product Portfolio Table 117. Thermo Fisher Scientific Recent Development Table 118. Samsung Biologics Company Information Table 119. Samsung Biologics Business Overview Table 120. Samsung Biologics Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Samsung Biologics Formulation Development CDMO Product Portfolio Table 122. Samsung Biologics Recent Development Table 123. AGC Biologics Company Information Table 124. AGC Biologics Business Overview Table 125. AGC Biologics Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AGC Biologics Formulation Development CDMO Product Portfolio Table 127. AGC Biologics Recent Development Table 128. WuXi AppTec Company Information Table 129. WuXi AppTec Business Overview Table 130. WuXi AppTec Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. WuXi AppTec Formulation Development CDMO Product Portfolio Table 132. WuXi AppTec Recent Development Table 133. Pharmaron Company Information Table 134. Pharmaron Business Overview Table 135. Pharmaron Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Pharmaron Formulation Development CDMO Product Portfolio Table 137. Pharmaron Recent Development Table 138. Asymchem Company Information Table 139. Asymchem Business Overview Table 140. Asymchem Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Asymchem Formulation Development CDMO Product Portfolio Table 142. Asymchem Recent Development Table 143. Huahai Pharma Company Information Table 144. Huahai Pharma Business Overview Table 145. Huahai Pharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Huahai Pharma Formulation Development CDMO Product Portfolio Table 147. Huahai Pharma Recent Development Table 148. Nipro Pharma Company Information Table 149. Nipro Pharma Business Overview Table 150. Nipro Pharma Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Nipro Pharma Formulation Development CDMO Product Portfolio Table 152. Nipro Pharma Recent Development Table 153. CMIC Group Company Information Table 154. CMIC Group Business Overview Table 155. CMIC Group Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. CMIC Group Formulation Development CDMO Product Portfolio Table 157. CMIC Group Recent Development Table 158. Hovione Company Information Table 159. Hovione Business Overview Table 160. Hovione Formulation Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Hovione Formulation Development CDMO Product Portfolio Table 162. Hovione Recent Development Table 163. North America Formulation Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Formulation Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Formulation Development CDMO Market Share by Country (2021-2026) Table 166. North America Formulation Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Formulation Development CDMO Market Share Forecast by Country (2027-2032) Table 168. Europe Formulation Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Formulation Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Formulation Development CDMO Market Share by Country (2021-2026) Table 171. Europe Formulation Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Formulation Development CDMO Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Formulation Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Formulation Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Formulation Development CDMO Market Share by Country (2021-2026) Table 176. Asia-Pacific Formulation Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Formulation Development CDMO Market Share Forecast by Country (2027-2032) Table 178. Latin America Formulation Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Formulation Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Formulation Development CDMO Market Share by Country (2021-2026) Table 181. Latin America Formulation Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Formulation Development CDMO Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Formulation Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Formulation Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Formulation Development CDMO Market Share by Country (2021-2026) Table 186. Middle East & Africa Formulation Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Formulation Development CDMO Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Formulation Development CDMO Product Image Figure 3. Global Formulation Development CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Formulation Development CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Formulation Development CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Formulation Development CDMO Market Share by Region (2021-2032) Figure 7. North America Formulation Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Formulation Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Formulation Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Formulation Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Formulation Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Oral Solid Dosage Forms Image Figure 13. Global Oral Solid Dosage Forms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Injectable Dosage Forms Image Figure 15. Global Injectable Dosage Forms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Transdermal Dosage Forms Image Figure 17. Global Transdermal Dosage Forms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Formulation Development CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Formulation Development CDMO Market Share by Type 2025 VS 2032 Figure 22. North America Formulation Development CDMO Market Size Share by Type (2021-2032) Figure 23. Europe Formulation Development CDMO Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Formulation Development CDMO Market Size Share by Type (2021-2032) Figure 25. Latin America Formulation Development CDMO Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Formulation Development CDMO Market Size Share by Type (2021-2032) Figure 27. Small molecule chemical drugs Image Figure 28. Global Small molecule chemical drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biologics Image Figure 30. Global Biologics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Cell and gene therapy products Image Figure 32. Global Cell and gene therapy products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Formulation Development CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Formulation Development CDMO Market Share by Application 2025 VS 2032 Figure 37. North America Formulation Development CDMO Market Size Share by Application (2021-2032) Figure 38. Europe Formulation Development CDMO Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Formulation Development CDMO Market Size Share by Application (2021-2032) Figure 40. Latin America Formulation Development CDMO Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Formulation Development CDMO Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Formulation Development CDMO Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Formulation Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Formulation Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Formulation Development CDMO Market Share by Country (2021-2032) Figure 47. Europe Formulation Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Formulation Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Formulation Development CDMO Market Share by Country (2021-2032) Figure 50. Asia-Pacific Formulation Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Formulation Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Formulation Development CDMO Market Share by Country (2021-2032) Figure 53. Latin America Formulation Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Formulation Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Formulation Development CDMO Market Share by Country (2021-2032) Figure 56. Middle East & Africa Formulation Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Formulation Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Formulation Development CDMO Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solid Dosage Forms
  • Injectable Dosage Forms
  • Transdermal Dosage Forms
  • Others
Applications
  • Small molecule chemical drugs
  • Biologics
  • Cell and gene therapy products
  • Others
Companies covered
  • Lonza
  • Ascendia Pharmaceutical Solutions
  • Catalent
  • Cambrex
  • Serán Bioscience
  • Singota Solutions
  • Adragos Pharma
  • Meribel Pharma
  • Eurofins CDMO
  • Skyepharma
  • Siegfried Group
  • Recipharm
  • CordenPharma
  • Thermo Fisher Scientific
  • Samsung Biologics
  • AGC Biologics
  • WuXi AppTec
  • Pharmaron
  • Asymchem
  • Huahai Pharma
  • Nipro Pharma
  • CMIC Group
  • Hovione

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Formulation Development CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Formulation Development CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Formulation Development CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Formulation Development CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Formulation Development CDMO Market Size (2021-2032)
  8. 1.5.1 North America Formulation Development CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Formulation Development CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Formulation Development CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Formulation Development CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Formulation Development CDMO Market Size Growth Rate (2021-2032)
2 Formulation Development CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Oral Solid Dosage Forms
  3. 2.1.2 Injectable Dosage Forms
  4. 2.1.3 Transdermal Dosage Forms
  5. 2.1.4 Others
  6. 2.2 Global Formulation Development CDMO Market Size by Type
  7. 2.2.1 Global Formulation Development CDMO Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Formulation Development CDMO Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Formulation Development CDMO Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Formulation Development CDMO Market Size by Regions
  11. 2.3.1 North America Formulation Development CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Formulation Development CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Formulation Development CDMO Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Formulation Development CDMO Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Formulation Development CDMO Market Size Breakdown by Type (2021-2026)
3 Formulation Development CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Small molecule chemical drugs
  3. 3.1.2 Biologics
  4. 3.1.3 Cell and gene therapy products
  5. 3.1.4 Others
  6. 3.2 Global Formulation Development CDMO Market Size by Application
  7. 3.2.1 Global Formulation Development CDMO Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Formulation Development CDMO Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Formulation Development CDMO Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Formulation Development CDMO Market Size by Regions
  11. 3.3.1 North America Formulation Development CDMO Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Formulation Development CDMO Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Formulation Development CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Formulation Development CDMO Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Formulation Development CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Formulation Development CDMO Industry Trends
  2. 4.2 Formulation Development CDMO Industry Drivers
  3. 4.3 Formulation Development CDMO Industry Opportunities and Challenges
  4. 4.4 Formulation Development CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Formulation Development CDMO Revenue (2021-2026)
  2. 5.2 Global Formulation Development CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Formulation Development CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Formulation Development CDMO Company, Product Type & Application
  5. 5.5 Global Formulation Development CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Formulation Development CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Formulation Development CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Formulation Development CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Formulation Development CDMO Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Ascendia Pharmaceutical Solutions
  8. 6.2.1 Ascendia Pharmaceutical Solutions Company Information
  9. 6.2.2 Ascendia Pharmaceutical Solutions Business Overview
  10. 6.2.3 Ascendia Pharmaceutical Solutions Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ascendia Pharmaceutical Solutions Formulation Development CDMO Product Portfolio
  12. 6.2.5 Ascendia Pharmaceutical Solutions Recent Developments
  13. 6.3 Catalent
  14. 6.3.1 Catalent Company Information
  15. 6.3.2 Catalent Business Overview
  16. 6.3.3 Catalent Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Catalent Formulation Development CDMO Product Portfolio
  18. 6.3.5 Catalent Recent Developments
  19. 6.4 Cambrex
  20. 6.4.1 Cambrex Company Information
  21. 6.4.2 Cambrex Business Overview
  22. 6.4.3 Cambrex Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Cambrex Formulation Development CDMO Product Portfolio
  24. 6.4.5 Cambrex Recent Developments
  25. 6.5 Serán Bioscience
  26. 6.5.1 Serán Bioscience Company Information
  27. 6.5.2 Serán Bioscience Business Overview
  28. 6.5.3 Serán Bioscience Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Serán Bioscience Formulation Development CDMO Product Portfolio
  30. 6.5.5 Serán Bioscience Recent Developments
  31. 6.6 Singota Solutions
  32. 6.6.1 Singota Solutions Company Information
  33. 6.6.2 Singota Solutions Business Overview
  34. 6.6.3 Singota Solutions Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Singota Solutions Formulation Development CDMO Product Portfolio
  36. 6.6.5 Singota Solutions Recent Developments
  37. 6.7 Adragos Pharma
  38. 6.7.1 Adragos Pharma Company Information
  39. 6.7.2 Adragos Pharma Business Overview
  40. 6.7.3 Adragos Pharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Adragos Pharma Formulation Development CDMO Product Portfolio
  42. 6.7.5 Adragos Pharma Recent Developments
  43. 6.8 Meribel Pharma
  44. 6.8.1 Meribel Pharma Company Information
  45. 6.8.2 Meribel Pharma Business Overview
  46. 6.8.3 Meribel Pharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Meribel Pharma Formulation Development CDMO Product Portfolio
  48. 6.8.5 Meribel Pharma Recent Developments
  49. 6.9 Eurofins CDMO
  50. 6.9.1 Eurofins CDMO Company Information
  51. 6.9.2 Eurofins CDMO Business Overview
  52. 6.9.3 Eurofins CDMO Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eurofins CDMO Formulation Development CDMO Product Portfolio
  54. 6.9.5 Eurofins CDMO Recent Developments
  55. 6.10 Skyepharma
  56. 6.10.1 Skyepharma Company Information
  57. 6.10.2 Skyepharma Business Overview
  58. 6.10.3 Skyepharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Skyepharma Formulation Development CDMO Product Portfolio
  60. 6.10.5 Skyepharma Recent Developments
  61. 6.11 Siegfried Group
  62. 6.11.1 Siegfried Group Company Information
  63. 6.11.2 Siegfried Group Business Overview
  64. 6.11.3 Siegfried Group Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Siegfried Group Formulation Development CDMO Product Portfolio
  66. 6.11.5 Siegfried Group Recent Developments
  67. 6.12 Recipharm
  68. 6.12.1 Recipharm Company Information
  69. 6.12.2 Recipharm Business Overview
  70. 6.12.3 Recipharm Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Recipharm Formulation Development CDMO Product Portfolio
  72. 6.12.5 Recipharm Recent Developments
  73. 6.13 CordenPharma
  74. 6.13.1 CordenPharma Company Information
  75. 6.13.2 CordenPharma Business Overview
  76. 6.13.3 CordenPharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 CordenPharma Formulation Development CDMO Product Portfolio
  78. 6.13.5 CordenPharma Recent Developments
  79. 6.14 Thermo Fisher Scientific
  80. 6.14.1 Thermo Fisher Scientific Company Information
  81. 6.14.2 Thermo Fisher Scientific Business Overview
  82. 6.14.3 Thermo Fisher Scientific Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Thermo Fisher Scientific Formulation Development CDMO Product Portfolio
  84. 6.14.5 Thermo Fisher Scientific Recent Developments
  85. 6.15 Samsung Biologics
  86. 6.15.1 Samsung Biologics Company Information
  87. 6.15.2 Samsung Biologics Business Overview
  88. 6.15.3 Samsung Biologics Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Samsung Biologics Formulation Development CDMO Product Portfolio
  90. 6.15.5 Samsung Biologics Recent Developments
  91. 6.16 AGC Biologics
  92. 6.16.1 AGC Biologics Company Information
  93. 6.16.2 AGC Biologics Business Overview
  94. 6.16.3 AGC Biologics Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AGC Biologics Formulation Development CDMO Product Portfolio
  96. 6.16.5 AGC Biologics Recent Developments
  97. 6.17 WuXi AppTec
  98. 6.17.1 WuXi AppTec Company Information
  99. 6.17.2 WuXi AppTec Business Overview
  100. 6.17.3 WuXi AppTec Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 WuXi AppTec Formulation Development CDMO Product Portfolio
  102. 6.17.5 WuXi AppTec Recent Developments
  103. 6.18 Pharmaron
  104. 6.18.1 Pharmaron Company Information
  105. 6.18.2 Pharmaron Business Overview
  106. 6.18.3 Pharmaron Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Pharmaron Formulation Development CDMO Product Portfolio
  108. 6.18.5 Pharmaron Recent Developments
  109. 6.19 Asymchem
  110. 6.19.1 Asymchem Company Information
  111. 6.19.2 Asymchem Business Overview
  112. 6.19.3 Asymchem Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Asymchem Formulation Development CDMO Product Portfolio
  114. 6.19.5 Asymchem Recent Developments
  115. 6.20 Huahai Pharma
  116. 6.20.1 Huahai Pharma Company Information
  117. 6.20.2 Huahai Pharma Business Overview
  118. 6.20.3 Huahai Pharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Huahai Pharma Formulation Development CDMO Product Portfolio
  120. 6.20.5 Huahai Pharma Recent Developments
  121. 6.21 Nipro Pharma
  122. 6.21.1 Nipro Pharma Company Information
  123. 6.21.2 Nipro Pharma Business Overview
  124. 6.21.3 Nipro Pharma Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Nipro Pharma Formulation Development CDMO Product Portfolio
  126. 6.21.5 Nipro Pharma Recent Developments
  127. 6.22 CMIC Group
  128. 6.22.1 CMIC Group Company Information
  129. 6.22.2 CMIC Group Business Overview
  130. 6.22.3 CMIC Group Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 CMIC Group Formulation Development CDMO Product Portfolio
  132. 6.22.5 CMIC Group Recent Developments
  133. 6.23 Hovione
  134. 6.23.1 Hovione Company Information
  135. 6.23.2 Hovione Business Overview
  136. 6.23.3 Hovione Formulation Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Hovione Formulation Development CDMO Product Portfolio
  138. 6.23.5 Hovione Recent Developments
7 North America
  1. 7.1 North America Formulation Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Formulation Development CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Formulation Development CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Formulation Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Formulation Development CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Formulation Development CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Formulation Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Formulation Development CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Formulation Development CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Formulation Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Formulation Development CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Formulation Development CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Formulation Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Formulation Development CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Formulation Development CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst